Glaucoma is a chronic, progressive disease in which retinal ganglion cells disappear and
subsequent, gradual reductions in the visual field ensues. Glaucoma eye drops have …

Corneal changes secondary to systemic medications may affect all layers of the cornea.
While corneal deposition is typically not an indication for drug cessation, patients receiving …

Topical ophthalmic medications are widely prescribed by growing numbers of eye-care
professionals. Increasingly, these agents are being prescribed by optometrists and …

This article reviews several retrospective case series and reported adverse events regarding
common ocular adverse effects related to systemic therapy. It is not intended as a …

PURPOSE: To review the more significant herbal and nutritional agents of clinical
importance to ophthalmologists and describe the ocular side effects for each. World Health …

Background: Sulphonamide‐derived medications are widely used, although not always
recognized as such. We report the occurrence of bilateral angle closure glaucoma with …

Written by experts in the field, this comprehensive resource offers valuable information on
the practical uses of drugs in primary eye care. Discussions of the pharmacology of ocular …

All psychotropic medications have the potential to induce numerous and diverse unwanted
ocular effects. Visual adverse effects can be divided into seven major categories: eyelid and …

Uveitis has been reported in association with a variety of topical, intraocular, periocular, and
systemic medications. To establish causality of adverse events by drugs, in 1981, Naranjo …

The safety profile of the different glaucoma medications is an important issue when initiating
therapy in glaucomatous patients. The decision on which medication to prescribe depends …